Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis

References

• Nanke Y, Kotake S, Akama H, Kamatani N. Alkaline phospha-tase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients. Cfin Rheumatol. 2002;21:198–202.
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345–52.
   PubMed Web of Science ®Google Scholar
• Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T, Yago T, et al. IFN-y-producing human T cells directly induce osteo-clastogenesis from human monocytes via the expression of RANKL. Eur J Immunol. 2005;35:3353–63.
   PubMed Web of Science ®Google Scholar
• Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003;63:12–23.
   Google Scholar
• Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:1946–9.
   PubMed Web of Science ®Google Scholar
• Grasser WA, Baumann AP, Petras SF, Harwood HJ Jr, Devalaraja R, Renkiewicz R, et al. Regulation of osteoclast differentiation by statins. J Musculoskelet Neuronal Interact. 2003;3:53–62.
   PubMedGoogle Scholar
• Garrett IR, Gutierrez G, Mundy GR. Statins and bone formation. Curr Pharm Des. 2001;7:715–36.
   Google Scholar
• Connor AM, Berger S, Narendran A, Keystone EC. Inhibition of protein geranylgeranylation induces apoptosis in synovial fibro-blasts. Arthritis Res 'Ther. 2006;8:R94.
   Google Scholar
• van Beek E, Lowik C, Karperien M, Papapoulos S. Independent pathways in the modulation of osteoclastic resorption by inter-mediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor. Bone. 2006;38:167–71.
   Google Scholar
• Sakoda K, Yamamoto M, Negishi Y, Liao JK, Nodo K, Izumi Y. Anti-inflammatory effects of simvastatin on human oral cells. Inflamm Regen. 2007;27(2):107–11.
   Google Scholar
• Nagashima T, Okazaki H, Yudoh K, Matsuno H, Minota S. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation. Arthritis Rheum. 2006; 54:579–86.
   Google Scholar
• Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T. Antiulcer effect of geranylgeranylacetone, a new acyclic polyi-soprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittelforschung. 1981;31:799–804.
   Google Scholar
• Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylace-tone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultures cells. Digestion. 1986;33:206–10.
   PubMed Web of Science ®Google Scholar
• Nanke Y, Kotake S, Ninomiya T, Furuya T, Ozawa H, Kamatani N. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats. Calcif Tissue Int. 2005;77:376–85.
   Google Scholar
• Nanke Y, Kotake S, Kamatani N. The role of gernylgernylace-tone in formation and function of osteoclasts. Osteoporos Jpn. 2004;12(2):69–72.
   Google Scholar
• Nanke Y, Kotake S, Kamatani N. The role of vitamin K2 and gernylgernylacetone in formation and function of osteoclast. In-flamm Regen. 2004;24: 173–7.
   Google Scholar
• Nanke Y, Kotake S, Kamatani N. Geranylgeranylacetone, and antiulcer drug, potently inhibits formation and function of human osteoclasts in vitro and bone loss in ovariectomized rats. Nippon Rinsho. 2004;63:575–9.
   Google Scholar
• Yanaka A, Zhang S, Sato D, Tauchi M, Suzuki H, Shibahara T, et al. Geranylgeranylacetone protects the human gastric mucosa from clic induced injury via induction of heat shock protein 70. Digestion. 2007;75:148–55.
   Google Scholar
• Tetsuya H, Rokutan K, Nikawa T, Kishi K. Geranylgeranylace-tone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology. 1999;111:345–57.
   Google Scholar
• Takano T, Tsutsumi S, Tomisato W, Hoshino T, Tsuchiya T. Geranylgeranylacetone protects guinea pig gastric mucosal cells from gastric stressor-induced apoptosis. Dig Dis Sci. 2002;47: 1546–53.
   Google Scholar
• Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylac-etone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology. 1996;111:345–7.
   PubMed Web of Science ®Google Scholar
• Shinohara T, Takahashi N, Kohno H, Yamanaka K, Ooie T, Wakisaka 0, et al. Mitochondria are targets for geranylger-anylacetone-induced cardio against ischemia-reperfusion in the rat heart. Am J Physiol Heart Circ Physiol. 2007;293: H1892–9.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Takahashi N, Ooie T, Kaneda K, Yoshimatsu H. Role of protein kinase C in geranylgernylacetone-induced expression of heat-shock protein 72 and cardioprotection in the rat heart. J Mol Cell Cardiol. 2003;35: 785–94.
   Google Scholar
• Suzuki S, Maruyama S, Sato W, Morita Y, Sato F, Mild Y, et al. Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp 70. Kidney Int. 2005;67:2210–20.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Nakao K, Nakata K, Hamasaki K, Takeda Y, Kajiya Y, et al. Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells. Biochem Biophys Res Commun. 2001;280:933–9.
   Google Scholar
• Fudaba Y, Tashiro H, Ohdan H, Miyata Y, Shibata S, Shintaku S, et al. Efficacy of HSP 72 induction in rat liver by orally admin-istrated geranylgernylacetone. Transpl Int. 2000;13:5278–81.
   Google Scholar
• Kitamei H, Kitaichi N, Yoshida K, Nakai A, Fujimoto M, Ki-tamura M, et al. Association of heat shock protein 70 induction and the amelioration experimental autoimmune uveoritinitis in mice. Immunobiology. 2007;212: 11–8.
   Google Scholar
• Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Yamanaka K, et al. Single oral dose of geranylgeranylacetone induces hear-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation. 2001;104:1837–43.
   PubMed Web of Science ®Google Scholar
• Harada C, Nakamura K, Guo X, Kitaichi N, Mitamura Y, Yos-hida K, et al. Neuroprotective effect of geranylgeranylacetone againt ischemia-in retinal injury. Mol Vis. 2007;13:1601–7.
   Google Scholar
• Nishida K, Ohta Y, Ishiguro I. Teprenone, an anti-ulcer agent, increases gastric mucosal mucus level via nitric oxide in rats. Jpn J Pharmacol. 1998;78(4):519–22.
   Google Scholar
• Fujiki M, Hikawa T, Abe T, Uchida S, Morishige M, Sugita K, et al. Role of protein kinase C in neuroprotective effect of ger-anylgeranylacetone, a noninvasive inducing agent of heat shock protein, on delayed neuronal death caused by transient ischemia in rats. J Neurotrauma. 2006;23:1164–78.
   Google Scholar
• Endo S, Hiramatsu N, Hayakawa K, Okamura M, Kasai A, Tagawa Y, et al. Geranylgeranylacetone, an inducer of H5P79, elicits unfolded prot response and coordinates cellular fate independently of HSP70. Mol Pharmacol. 2007;72:1337–48.
   PubMedGoogle Scholar
• Uchida S, Fujiki M, Nagai Y, Abe T, Kobayashi H. Geranyl-geranylacetone, a noninvasive heat shock protein inducer, in protein kinase C and leads to neuroprotection against cerebral infarction in rats. Neurosci Lett. 2006;396:220–4.
   Google Scholar
• Rokutan K, Teshima S, Kawai T, Kawahara T, Kusumoro K, Mizushima T, et al. Geranylgeranylacetone stimulates mucin synthesis in cultured guinea pig gastric pit cells by inducing a neuronal nitric oxide syntheses. J Gastroenterol. 2000;35:673–81.
   Google Scholar
• Brundel BJ, Shiroshita-Takeshita A, Qi X, Yeh YH, Chartier D, van Gelder IC, et al. Induction of heat shock response protects the heart against atrial fibrillation. Circ Res. 2006;99:1394–402.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Sarukawa M, Ito T, Aoki H, Ichida M, Shimada K. An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitrogen syntheses in cultured vascular smooth muscle cells. J Hypertens. 2005;10:1847–53.
   Google Scholar
• Hirota K, Nakamura H, Arai T, Ishii H, Bai J, Itoh T, et al. Geranylgeranylacetone enhances expression of thioredoxin and supresses ethanol-induced cytotoxicity in cultured hepatocytes. Biochem Biophys Res Commun. 2000;275:825–30.
   PubMed Web of Science ®Google Scholar
• Sone M, Hayashi H, Yamamoto H, Hashino T, Mizushima T, Nakashima T. Up regulation of HSP by geranylgeranylacetone protects the cochlear wall from endotoxin-induced inflammation. Hear Res. 2005;204:140–6.
   Google Scholar
• Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE, Giffard RG. Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad. 2005;1053:74–83.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Morishige K, Sawada K, Ogata S, Tahara M, Shimizu S, et al. Geranylgeranylacetone inhibits ovarian cancer progression in vitro. Biochem Biophys Res Commun. 2007;356:72–7.
   Google Scholar
• Nishida T, Yabe Y, Fu HY, Hayashi Y, Asahi K, Eguchi H, et al. Geranylgeranylacetone induces cyclooxygenase-2 expression in culture gastric epithelial cells through NF-kappaB. Dig Dis Sci. 2007;8:1890–6.
   Google Scholar
• Wojcik C, Napoli N. Ubiquitin-proteasome system and protea-some inhibition: new strategies in stroke therapy. Stroke. 2004;35:1506–18.
   PubMed Web of Science ®Google Scholar
• Okada S, Yabuki M, Kanno T, Hamazaki K, Yoshioka T, Horton AA, et al. Geranylgeranylacetone induces apoptosis in HL-60. Cell Struct Funct. 1999;24:161–8.
   Google Scholar
• Kinderlerer AR, Steinberg R, Johns M, Harten SK, Lidington EA, Haskard DO, et al. Statin-induced expression of CD59 on vas-cular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis. Arthritis Res Ther. 2006;8:R130.
   PubMed Web of Science ®Google Scholar
• Kinderlerer AR, Steinberg R, Johns M, Harten SK, Lidington EA, Haskard DO, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003;170:1524–30.
   Google Scholar
• Kanda H, Hamasaki K, Kubo K, Tateishi S, Yonezumi A, Kanda Y, et al. Anti-inflammatory effect of simvastatin in patients with rheumatoid arthritis. J Rheumatol. 2002;29:2024–5.
   PubMed Web of Science ®Google Scholar
• Jansen TL. Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis. Rheumatology. 2006;45:1577–8.
   Google Scholar
• McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov 0, Ford I, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo-controlled trial. Lancet. 2006;363: 2015–21.
   Google Scholar
• Xu H, Liu P, Liang L, Danesh FR, Yang X, Ye Y, et al. RhoA-medicated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simva-statin. Arthris Rheum. 2006;54:3441–51.
   Google Scholar
• Goto M, Sasano M, Yamanaka H, Miyasaka N, Kamatani N, Inoue K, et al. Spontaneous production of an interleukin- 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest. 1987;80:786–96.
   PubMed Web of Science ®Google Scholar